US And EU Regulators Eye Co-operation In Expedited Pathways
Executive Summary
US and EU regulatory experts could soon be strengthening ties. They're considering a pilot program to discuss the scientific advice they provide to companies in the field of oncology under two expedited pathways programs, breakthrough therapy in the US and PRIME in the EU.